1523437-16-2(ML291)

1523437-16-2 Basic information More..
Product Name:ML291
Synonyms:ML291;ML291 >=98% (HPLC);2-Furancarboxamide, N-[4-[(4-chloro-1-piperidinyl)sulfonyl]phenyl]-5-nitro-;CHOP Activator, Cpd12
CAS:1523437-16-2
MF:C16H16ClN3O6S
MW:413.83
EINECS:808-922-2
Mol File:Mol File
1523437-16-2
Information Error Report
Your Email:
Browse by Nationality 1523437-16-2 Suppliers China suppliers
United States(3) Member(3) All(3)
1523437-16-2 Recommend Suppliers
Recommend You Select Member Companies.
Company Name: TargetMol Chemicals Inc.    Recommend    Complaint
Tel:
Email: support@targetmol.com
Nationality: United States
Products Intro: Product Name:ML-291
CAS:1523437-16-2
Package:2mg;60USD
CB Index: 58
WebSite: www.targetmol.com/
Related Information: Sales Network   Catalog(38630)   User Evaluation
Company Name: ApexBio Technology    Recommend    Complaint
Tel: + 1-832-696-8203
Email: sales@apexbt.com
Nationality: United States
Products Intro: Product Name:ML-291
CAS:1523437-16-2
CB Index: 58
WebSite: www.apexbt.com
Related Information: Sales Network   Catalog(6251)   User Evaluation
Company Name: Cayman Chemical Company    Recommend    Complaint
Tel: (800) 364-9897
Email: cayman@caymanchem.com
Nationality: United States
Products Intro: Product Name:ML-291
CAS:1523437-16-2
CB Index: 81
WebSite: www.caymanchem.com
Related Information: Sales Network   Catalog(6213)   User Evaluation
1
Tag: 1523437-16-2
  • HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.